We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+8.03%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.26B
AUM Growth
+$69.7M
Cap. Flow
+$21.1M
Cap. Flow %
1.68%
Top 10 Hldgs %
3.22%
Holding
2,074
New
640
Increased
457
Reduced
456
Closed
520

Top Buys

Rank Stock Value
1
ZTS icon
Zoetis
ZTS
+$3.54M
2
MNST icon
Monster Beverage
MNST
+$3.4M
3
UGI icon
UGI
UGI
+$3.25M
4
LMND icon
Lemonade
LMND
+$3.18M
5
APA icon
APA Corp
APA
+$3.05M

Top Sells

Rank Stock Value
1
CRH icon
CRH
CRH
+$4.73M
2
AON icon
Aon
AON
+$4.58M
3
ZG icon
Zillow
ZG
+$4.44M
4
URNM icon
Sprott Uranium Miners ETF
URNM
+$4.08M
5
BWXT icon
BWX Technologies
BWXT
+$3.63M

Sector Composition

Rank Sector Weight
1 Technology 15.86%
2 Financials 12.61%
3 Healthcare 12.06%
4 Consumer Discretionary 11.89%
5 Industrials 9.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NOMD icon
1351
Nomad Foods
NOMD
$1.68B
$227K 0.02%
+11,582
New +$213K
AMLX icon
1352
Amylyx Pharmaceuticals
AMLX
$2.54B
$226K 0.02%
79,652
-52,525
-40% -$687K
WPC icon
1353
W.P. Carey
WPC
$16.4B
$226K 0.02%
+3,996
New +$239K
AAMI
1354
Acadian Asset Management
AAMI
$3.19B
$226K 0.02%
9,904
-67,358
-87% -$1.45M
FWRG icon
1355
First Watch Restaurant Group
FWRG
$766M
$225K 0.02%
+9,138
New +$207K
LFMD icon
1356
LifeMD
LFMD
$172M
$225K 0.02%
+21,902
New +$162K
MLNK
1357
DELISTED
MeridianLink
MLNK
$224K 0.02%
+11,964
New +$244K
URGN icon
1358
UroGen Pharma
URGN
$2.29B
$224K 0.02%
+14,937
New +$244K
UTMD icon
1359
Utah Medical Products
UTMD
$225M
$224K 0.02%
+3,151
New +$236K
SMHI icon
1360
SEACOR Marine Holdings
SMHI
$258M
$223K 0.02%
+15,981
New +$185K
ASAN icon
1361
Asana
ASAN
$2.13B
$222K 0.02%
14,354
-1,170
-8% -$20.9K
LGTY
1362
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$222K 0.02%
19,351
+3,362
+21% +$37.9K
KCE icon
1363
State Street SPDR S&P Capital Markets ETF
KCE
$466M
$221K 0.02%
+2,002
New +$207K
LRMR icon
1364
Larimar Therapeutics
LRMR
$432M
$221K 0.02%
29,062
+3,830
+15% +$29.8K
APO icon
1365
Apollo Global Management
APO
$73.4B
$220K 0.02%
1,959
-1,794
-48% -$189K
CLFD icon
1366
Clearfield
CLFD
$374M
$220K 0.02%
7,120
-4,426
-38% -$127K
GRVY
1367
GRAVITY
GRVY
$473M
$220K 0.02%
+2,893
New +$202K
KGC icon
1368
Kinross Gold
KGC
$32.8B
$220K 0.02%
+35,934
New +$195K
PZZA icon
1369
Papa John's
PZZA
$806M
$220K 0.02%
+3,305
New +$239K
RICK icon
1370
RCI Hospitality Holdings
RICK
$215M
$220K 0.02%
+3,791
New +$223K
EMGF icon
1371
iShares Emerging Markets Equity Factor ETF
EMGF
$1.87B
$219K 0.02%
4,912
ENLC
1372
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$219K 0.02%
+16,036
New +$199K
EVH icon
1373
Evolent Health
EVH
$447M
$218K 0.02%
+6,654
New +$212K
SAGE
1374
DELISTED
Sage Therapeutics
SAGE
$218K 0.02%
11,655
-58,724
-83% -$1.35M
VOYA icon
1375
Voya Financial
VOYA
$9.19B
$218K 0.02%
+2,946
New +$208K

Similar funds

GSA Capital Partners's Q1 2024 Portfolio in Review

As of Q1 2024, GSA Capital Partners held 2,074 positions worth $1.26B, up 5.9% from $1.19B the previous quarter. Its ten largest holdings account for 3.2% of the portfolio.

GSA Capital Partners's Q1 2024 filing shows 640 new, 457 increased, 456 reduced and 520 closed positions. Its largest new stake was Zoetis: 18,907 shares worth $3.2M. The largest sale was CRH, an estimated $4.73M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

  • GSA Capital Partners's largest Q1 2024 buy was Zoetis: 18,907 shares worth $3.2M.
  • GSA Capital Partners added most to Monster Beverage in Q1 2024, an estimated $3.4M increase.
  • GSA Capital Partners's biggest Q1 2024 reduction was CRH, cutting an estimated $4.73M.
  • GSA Capital Partners fully exited Aon in Q1 2024, selling an estimated $4.58M.
  • GSA Capital Partners's ten largest holdings make up 3.2% of its $1.26B portfolio in Q1 2024.
  • GSA Capital Partners opened 640 new positions and closed 520 in Q1 2024.
  • GSA Capital Partners's portfolio value rose 5.9% quarter-over-quarter to $1.26B.

Based on GSA Capital Partners's 13F filing for Q1 2024, filed 3 May 2024.